Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pCLXSN Citations (3)

Originally described in: The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses.
Naviaux RK, Costanzi E, Haas M, Verma IM J Virol. 1996 Aug . 70(8):5701-5. PubMed

Articles Citing pCLXSN

Articles
Identification of targetable recurrent MAP3K8 rearrangements in melanomas lacking known driver mutations. Lehmann BD, Shaver TM, Johnson DB, Li Z, Gonzalez-Ericsson PI, Sanchez V, Shyr Y, Sanders ME, Pietenpol JA. Mol Cancer Res. 2019 Jun 11. pii: 1541-7786.MCR-19-0257. doi: 10.1158/1541-7786.MCR-19-0257. PubMed
Novel Role of Prereplication Complex Component Cell Division Cycle 6 in Retinal Neovascularization. Kumar R, Rao GN. Arterioscler Thromb Vasc Biol. 2022 Apr;42(4):407-427. doi: 10.1161/ATVBAHA.121.317182. Epub 2022 Mar 3. PubMed
RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity. Barua D, Sultana A, Islam MN, Cox F, Gupta A, Gupta S. BMC Cancer. 2023 Mar 30;23(1):288. doi: 10.1186/s12885-023-10745-1. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.